Bank of Montreal’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $220K | Buy |
+62,750
| New | +$257K | ﹤0.01% | 2872 |
|
|
2025
Q2 | – | Sell |
-16,677
| Closed | -$24.5K | – | 3635 |
|
|
2025
Q1 | $24.5K | Sell |
16,677
-8,081
| -33% | -$19.2K | ﹤0.01% | 3184 |
|
|
2024
Q4 | $110K | Buy |
24,758
+11,089
| +81% | +$45K | ﹤0.01% | 2932 |
|
|
2024
Q3 | $54.9K | Sell |
13,669
-80,895
| -86% | -$435K | ﹤0.01% | 3392 |
|
|
2024
Q2 | $618K | Buy |
94,564
+80,317
| +564% | +$568K | ﹤0.01% | 2290 |
|
|
2024
Q1 | $125K | Buy |
14,247
+664
| +5% | +$8.06K | ﹤0.01% | 3228 |
|
|
2023
Q4 | $156K | Buy |
13,583
+2,737
| +25% | +$27.1K | ﹤0.01% | 3227 |
|
|
2023
Q3 | $98.3K | Sell |
10,846
-5,502
| -34% | -$53.9K | ﹤0.01% | 3287 |
|
|
2023
Q2 | $181K | Sell |
16,348
-1,510
| -8% | -$16.2K | ﹤0.01% | 3254 |
|
|
2023
Q1 | $203K | Buy |
17,858
+4,324
| +32% | +$48.4K | ﹤0.01% | 3010 |
|
|
2022
Q4 | $169K | Sell |
13,534
-107
| -0.8% | -$1.21K | ﹤0.01% | 3216 |
|
|
2022
Q3 | $143 | Sell |
13,641
-2,072
| -13% | -$23.5K | ﹤0.01% | 3335 |
|
|
2022
Q2 | $193 | Buy |
15,713
+14,186
| +929% | +$167K | ﹤0.01% | 3285 |
|
|
2022
Q1 | $19K | Buy |
+1,527
| New | +$17.5K | ﹤0.01% | 3931 |
|
|
2021
Q4 | – | Sell |
-1,532
| Closed | -$20K | – | 3672 |
|
|
2021
Q3 | $20K | Hold |
1,532
| – | – | ﹤0.01% | 3663 |
|
|
2021
Q2 | $20K | Sell |
1,532
-4,635
| -75% | -$53.1K | ﹤0.01% | 3506 |
|
|
2021
Q1 | $64K | Sell |
6,167
-20,099
| -77% | -$212K | ﹤0.01% | 3601 |
|
|
2020
Q4 | $306K | Buy |
26,266
+17,330
| +194% | +$190K | ﹤0.01% | 2982 |
|
|
2020
Q3 | $85K | Sell |
8,936
-5,585
| -38% | -$55.5K | ﹤0.01% | 3165 |
|
|
2020
Q2 | $143K | Buy |
14,521
+12,565
| +642% | +$129K | ﹤0.01% | 2901 |
|
|
2020
Q1 | $20K | Sell |
1,956
-19,169
| -91% | -$225K | ﹤0.01% | 3247 |
|
|
2019
Q4 | $281K | Buy |
21,125
+7,649
| +57% | +$84.3K | ﹤0.01% | 2978 |
|
|
2019
Q3 | $116K | Sell |
13,476
-1,897
| -12% | -$18.4K | ﹤0.01% | 3218 |
|
|
2019
Q2 | $168K | Buy |
15,373
+12,689
| +473% | +$142K | ﹤0.01% | 3025 |
|
|
2019
Q1 | $27K | Sell |
2,684
-17,430
| -87% | -$195K | ﹤0.01% | 3562 |
|
|
2018
Q4 | $175K | Buy |
20,114
+16,297
| +427% | +$187K | ﹤0.01% | 2651 |
|
|
2018
Q3 | $59K | Sell |
3,817
-2,185
| -36% | -$34.5K | ﹤0.01% | 3317 |
|
|
2018
Q2 | $96K | Buy |
6,002
+2,804
| +88% | +$41.5K | ﹤0.01% | 3137 |
|
|
2018
Q1 | $42K | Sell |
3,198
-66,695
| -95% | -$831K | ﹤0.01% | 3305 |
|
|
2017
Q4 | $877K | Sell |
69,893
-2,940
| -4% | -$38.4K | ﹤0.01% | 2022 |
|
|
2017
Q3 | $962K | Sell |
72,833
-6,672
| -8% | -$91.8K | ﹤0.01% | 1991 |
|
|
2017
Q2 | $1.26M | Sell |
79,505
-37,853
| -32% | -$550K | ﹤0.01% | 1875 |
|
|
2017
Q1 | $1.68M | Sell |
117,358
-15,571
| -12% | -$213K | ﹤0.01% | 1626 |
|
|
2016
Q4 | $1.74M | Buy |
132,929
+110,618
| +496% | +$1.4M | ﹤0.01% | 1641 |
|
|
2016
Q3 | $297K | Buy |
22,311
+20,335
| +1,029% | +$238K | ﹤0.01% | 2291 |
|
|
2016
Q2 | $22K | Sell |
1,976
-1,502
| -43% | -$14.7K | ﹤0.01% | 3349 |
|
|
2016
Q1 | $32K | Buy |
3,478
+1,329
| +62% | +$11K | ﹤0.01% | 3210 |
|
|
2015
Q4 | $21K | Buy |
2,149
+647
| +43% | +$6.25K | ﹤0.01% | 3368 |
|
|
2015
Q3 | $13K | Buy |
+1,502
| New | +$14K | ﹤0.01% | 3393 |
|
|
2014
Q3 | – | Sell |
-3,045
| Closed | -$39K | – | 4204 |
|
|
2014
Q2 | $39K | Buy |
+3,045
| New | +$33.1K | ﹤0.01% | 3315 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Bank of Montreal's IRWD Position: Q1 2026 in Review
Bank of Montreal opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 62,750 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #2872 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in IRWD as recently as Q1 2025.
Bank of Montreal first reported a position in IRWD in Q2 2014 and has held it in 40 quarters since. The position peaked at $1.74M in Q4 2016. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Bank of Montreal held 62,750 shares of Ironwood Pharmaceuticals worth $220K as of Q1 2026.
- Ironwood Pharmaceuticals was a new Bank of Montreal position in Q1 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2872 holding.
- Bank of Montreal first reported a position in Ironwood Pharmaceuticals in Q2 2014 and has held it in 40 quarters since.
- Bank of Montreal's Ironwood Pharmaceuticals position peaked at $1.74M in Q4 2016.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.